search
Back to results

Sedation Optimisation Strategy (S.O.S.) Ventilation

Primary Purpose

Surgery, Critical Illness, Mechanical Ventilation Complication

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Therapy strategy
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Surgery focused on measuring Surgery, Critical illness, Mechanical ventilation, Organ dysfunction syndrome, Intensive Care Units Sedation, Analgesia, Treatment protocol, Nursing protocol, Outcome, Pain, Neurological disorders, Delirium, Muscular weakness, Psychological disorders, Anxiety, Depression, Stress disorders, Post-Traumatic

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Ventilated patient in assist control mode after a surgical procedure expected to be ventilated for 12-hours or more
  • At least 1 organ dysfunction according to SOFA score
  • Non paralyzed because of neuromuscular blocking agents
  • Body temperature > or equal 36°CAge > or equal 18
  • Surrogate decision maker's consent

Exclusion Criteria:

  • Patients without any surgical procedure (medical patients)
  • Continuous mechanical ventilation for 24-hours or longer
  • Hospitalisation in ICU for 7-days or longer
  • Severe ARDS (Acrasis study criteria, New England J Med 2011)
  • Neurological injury
  • Active toxicomania
  • Reduction or cessation of active treatment
  • Patient under tutelage
  • Pregnancy
  • No French health insurance
  • Enrollment in another study on sedation or mechanical ventilation

Sites / Locations

  • Department of Anesthesiology & Critical Care, Estaing University Hospital
  • Department of Anesthesiology & Critical Care, St Eloi University Hospital
  • Department of Anesthesiology & Critical Care, Caremeau University Hospita

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

No Intervention

Arm Label

S.O.S.-V

Standard

Arm Description

Outcomes

Primary Outcome Measures

Time to successful intubation
Time to successful intubation is defined as time from randomization to extubation (or tracheotomy mask) for 48 hours.

Secondary Outcome Measures

Dose and duration of sedation
Dose and duration of sedation
Type and duration of mechanical ventilation
Type and duration of mechanical ventilation
Complications acquired in ICU
Complications acquired in ICU stress ulcers ileus infections delirium neuromuscular weakness pain
Length of stay in ICU and hospital
Length of stay in ICU and hospital
Mortality
ICU mortality, 3 months mortality and 12 months mortality
Quality of life, anxiety, depression, post-traumatic stress disorder 3 and 12 months after ICU discharge
Quality of life, anxiety, depression, post-traumatic stress disorder 3 and 12 months after ICU discharge
Incidence and duration of organ dysfunctions
Incidence and duration of organ dysfunctions

Full Information

First Posted
November 10, 2011
Last Updated
December 1, 2015
Sponsor
University Hospital, Montpellier
search

1. Study Identification

Unique Protocol Identification Number
NCT01486121
Brief Title
Sedation Optimisation Strategy (S.O.S.) Ventilation
Official Title
S.O.S. Ventilation - Sedation Optimisation Strategy For Mechanical Ventilation In Intensive Care Unit Patients
Study Type
Interventional

2. Study Status

Record Verification Date
December 2015
Overall Recruitment Status
Completed
Study Start Date
December 2011 (undefined)
Primary Completion Date
April 2015 (Actual)
Study Completion Date
April 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Use of sedatives and analgesics is common in mechanically ventilated patients hospitalized in Intensive Care Unit (ICU). That is called " sedation " and aimed to reduce both pain and anxiety and also to allow an effective and atraumatic mechanical ventilation. However, sedation excess and ventilator support excess, both in duration and intensity, are associated with an excess morbidity. Patients usually are systematically sedated after having been intubated. Then, sedation is stopped first before ventilator support is weaning. Several studies shown that rationalized protocols of sedation and ventilation orderings had a beneficial impact on non surgical patients' outcome. Feasibility of these protocols in surgical patients is still unknown. Moreover, no study has evaluated an optimized paired strategy of sedation-ventilation based on the priority setting of ventilation. This priority setting of ventilation should increase patient's comfort in spite of increasing sedatives and analgesics dosing. An paired sedation-ventilation protocol optimized for both duration and intensity of these treatments could improve surgical patients' outcome in ICU.
Detailed Description
Intervention group: Continuous use of sedatives and analgesics (commonly called "sedation") will be stopped upon enrolment. Ventilator asynchrony in Volume assist Controlled Ventilation (VCV) will be treated by switching to Pressure Support Ventilation (PSV) or adjusting setting of VCV. Pain, anxiety and agitation will be treated by priority setting of the mechanical ventilator aimed to deliver the most comfortable ventilator support and secondly by adding analgesics and/or psychoactive drugs without inducing a coma state.- Persistent ventilator asynchrony or persistent agitation will be treated by 6-hours continuous sedation periods. Extubation will be performed according to criteria defined by the national consensus on mechanical ventilation weaning, which are based on a daily spontaneous breathing trial in the absence of any sedation. Control group (standard practices): Continuous use of sedatives and analgesics (commonly called "sedation") will be daily stopped according to criteria defined by the national consensus on sedation for ICU patients.- During the period before the interruption of sedation, ventilator asynchrony in VCV will be treated by increasing the depth of sedation and then the dose of opioids. During the period before the interruption of sedation, pain, anxiety and agitation will be treated by a priority adjustment of sedation according to the nurse driven protocol recommended by the national consensus on sedation for ICU patients.- During the period after the interruption of sedation, ventilator asynchrony will be treated by switching to the PSV mode. In case of return to VCV, asynchrony will be treated by restart of sedation. During the period after the interruption of sedation, pain, anxiety and agitation will be treated as for the intervention group. Extubation will be performed according to criteria defined by the national consensus on mechanical ventilation weaning, which are based on a daily spontaneous breathing trial in the absence of any sedation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Surgery, Critical Illness, Mechanical Ventilation Complication, Organ Dysfunction Syndrome, Intensive Care Unit Syndrome
Keywords
Surgery, Critical illness, Mechanical ventilation, Organ dysfunction syndrome, Intensive Care Units Sedation, Analgesia, Treatment protocol, Nursing protocol, Outcome, Pain, Neurological disorders, Delirium, Muscular weakness, Psychological disorders, Anxiety, Depression, Stress disorders, Post-Traumatic

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
140 (Actual)

8. Arms, Groups, and Interventions

Arm Title
S.O.S.-V
Arm Type
Other
Arm Title
Standard
Arm Type
No Intervention
Intervention Type
Other
Intervention Name(s)
Therapy strategy
Intervention Description
Sedation & mechanical ventilation
Primary Outcome Measure Information:
Title
Time to successful intubation
Description
Time to successful intubation is defined as time from randomization to extubation (or tracheotomy mask) for 48 hours.
Time Frame
for 48 hours after intubation
Secondary Outcome Measure Information:
Title
Dose and duration of sedation
Description
Dose and duration of sedation
Time Frame
Day 0 to Days 28
Title
Type and duration of mechanical ventilation
Description
Type and duration of mechanical ventilation
Time Frame
Day 0 to Days 28
Title
Complications acquired in ICU
Description
Complications acquired in ICU stress ulcers ileus infections delirium neuromuscular weakness pain
Time Frame
Days 28
Title
Length of stay in ICU and hospital
Description
Length of stay in ICU and hospital
Time Frame
up to 6 months
Title
Mortality
Description
ICU mortality, 3 months mortality and 12 months mortality
Time Frame
up to 12 months
Title
Quality of life, anxiety, depression, post-traumatic stress disorder 3 and 12 months after ICU discharge
Description
Quality of life, anxiety, depression, post-traumatic stress disorder 3 and 12 months after ICU discharge
Time Frame
up to 6 months
Title
Incidence and duration of organ dysfunctions
Description
Incidence and duration of organ dysfunctions
Time Frame
Day 1 to Days 5

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Ventilated patient in assist control mode after a surgical procedure expected to be ventilated for 12-hours or more At least 1 organ dysfunction according to SOFA score Non paralyzed because of neuromuscular blocking agents Body temperature > or equal 36°CAge > or equal 18 Surrogate decision maker's consent Exclusion Criteria: Patients without any surgical procedure (medical patients) Continuous mechanical ventilation for 24-hours or longer Hospitalisation in ICU for 7-days or longer Severe ARDS (Acrasis study criteria, New England J Med 2011) Neurological injury Active toxicomania Reduction or cessation of active treatment Patient under tutelage Pregnancy No French health insurance Enrollment in another study on sedation or mechanical ventilation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gerald GC Chanques, MD, PhD
Organizational Affiliation
UH, Montpellier
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Anesthesiology & Critical Care, Estaing University Hospital
City
Clermont-Ferrand
ZIP/Postal Code
63000
Country
France
Facility Name
Department of Anesthesiology & Critical Care, St Eloi University Hospital
City
Montpellier
ZIP/Postal Code
34000
Country
France
Facility Name
Department of Anesthesiology & Critical Care, Caremeau University Hospita
City
Nimes
ZIP/Postal Code
30000
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
28935558
Citation
Chanques G, Conseil M, Roger C, Constantin JM, Prades A, Carr J, Muller L, Jung B, Belafia F, Cisse M, Delay JM, de Jong A, Lefrant JY, Futier E, Mercier G, Molinari N, Jaber S; SOS-Ventilation study investigators. Immediate interruption of sedation compared with usual sedation care in critically ill postoperative patients (SOS-Ventilation): a randomised, parallel-group clinical trial. Lancet Respir Med. 2017 Oct;5(10):795-805. doi: 10.1016/S2213-2600(17)30304-1. Epub 2017 Sep 18.
Results Reference
derived

Learn more about this trial

Sedation Optimisation Strategy (S.O.S.) Ventilation

We'll reach out to this number within 24 hrs